Discover
Stroke News & Brain Health - American Heart Association
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke

PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
Update: 2025-11-08
Share
Description
Research Highlights:
Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor...
Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor...
Comments
In Channel



